$CUR Company News Neuralstem gets FDA okay for
Post# of 102911
Posted On: 08/11/2014 12:28:45 PM
$CUR Company News
Neuralstem gets FDA okay for depression study 10:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 5:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 5:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 7:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 7:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 3:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 3:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 2:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 2:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 3:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 4:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 11:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 10:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 2:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 2:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 6:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 1:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 9:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 12:36 p.m. April 13, 2007 - Greg Presto
10-Q: NEURALSTEM, INC. 6:24 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Researchers Fret as Social Media Lift Drug-Trial Veil 10:30 p.m. July 29, 2014 - The Wall Street Journal Interactive Edition
Second site begins enrolling patients in BrainStorm ALS trial 11:05 a.m. July 15, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 9:35 a.m. July 7, 2014 - Seeking Alpha
An Early Valuation Of Neuralstem's NSI-189 For MDD 9:34 a.m. June 26, 2014 - Seeking Alpha
BrainStorm Tackles Neurodegenerative Diseases With Novel Cell Therapy 1:44 p.m. June 12, 2014 - Seeking Alpha
Neuralstem NSI-189 Abstract Teases At Potential Greatness 9:14 a.m. May 28, 2014 - Seeking Alpha
Interesting CUR Put And Call Options For July 19th 12:10 p.m. May 19, 2014 - TheStreet.com
A trader's look at Neuralstem 3:07 p.m. May 14, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 6:29 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
BrainStorm to start Phase 2 ALS trial 10:12 a.m. April 28, 2014 - Seeking Alpha
Interesting CUR Put And Call Options For June 21st 11:54 a.m. April 22, 2014 - TheStreet.com
Neuralstem's Cell Therapy Is Working, And This Is Just The Beginning 8:41 a.m. April 22, 2014 - Seeking Alpha
Stem cell trial for spinal cord injury to proceed 10:02 a.m. April 16, 2014 - Seeking Alpha
Aastrom: Mice Scared Me Away 10:51 a.m. March 26, 2014 - Seeking Alpha
Senators introduce regenerative medicine bill 1:40 p.m. March 14, 2014 - Seeking Alpha
Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS 10:30 a.m. March 11, 2014 - Seeking Alpha
Osiris Therapeutics: Poised For Another Breakout 2:07 a.m. March 11, 2014 - Seeking Alpha
Major stem cell discovery might not be so major 2:32 p.m. March 10, 2014 - Seeking Alpha
10-K: NEURALSTEM, INC. 6:30 a.m. March 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial 9:15 a.m. Aug. 4, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks -- Research on Dynavax Technologies, Synergy Pharma, Infinity Pharma, and Neuralstem 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder 9:15 a.m. June 25, 2014 - PR Newswire - PRF
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress 9:15 a.m. June 19, 2014 - PR Newswire - PRF
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting 9:15 a.m. June 18, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "The FDA is Not the Enemy" 9:26 a.m. June 9, 2014 - ACCESSWIRE
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 6:50 a.m. May 29, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "Most men would rather deny a hard truth than face it" 11:36 a.m. May 28, 2014 - ACCESSWIRE
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting 9:28 a.m. May 23, 2014 - PR Newswire - PRF
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update 9:15 a.m. May 12, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings 1:34 p.m. May 9, 2014 - PR Newswire - PRF
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors 9:15 a.m. May 8, 2014 - PR Newswire - PRF
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego 9:15 a.m. April 16, 2014 - PR Newswire - PRF
Equities Updates on Top Gainers -- Research on E-Commerce China Dangdang, Neuralstem, Cytokinetics, and Nu Skin Enterprises 1:30 p.m. April 10, 2014 - PR Newswire - PRF
Neuralstem Principal Investigator, Dr. Eva Feldman, To Present Published ALS Trial Phase I Data At Medical Conference 9:15 a.m. April 7, 2014 - PR Newswire - PRF
Study Shows Neuralstem Cells Transplanted Into Brain Significantly Improve Post-Stroke Symptoms in Rats 9:15 a.m. March 28, 2014 - PR Newswire - PRF
Equities Recording New Highs: Generac Holding, Sempra Energy, Neuralstem, and Great Plains Energy 9:41 a.m. March 18, 2014 - PR Newswire - PRF
Final Results Of Neuralstem Phase I Stem Cell Trial In Amyotrophic Lateral Sclerosis Published In Annals of Neurology 9:15 a.m. March 17, 2014 - PR Newswire - PRF
Breakthroughs on the Horizon for CTE and Other Neurodegenerative Diseases 1:22 p.m. March 13, 2014 - ACCESSWIRE
Neuralstem gets FDA okay for depression study 10:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 5:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 5:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 7:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 7:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 3:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 3:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 2:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 2:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 3:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 4:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 11:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 10:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 2:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 2:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 6:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 1:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 9:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 12:36 p.m. April 13, 2007 - Greg Presto
10-Q: NEURALSTEM, INC. 6:24 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Researchers Fret as Social Media Lift Drug-Trial Veil 10:30 p.m. July 29, 2014 - The Wall Street Journal Interactive Edition
Second site begins enrolling patients in BrainStorm ALS trial 11:05 a.m. July 15, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 9:35 a.m. July 7, 2014 - Seeking Alpha
An Early Valuation Of Neuralstem's NSI-189 For MDD 9:34 a.m. June 26, 2014 - Seeking Alpha
BrainStorm Tackles Neurodegenerative Diseases With Novel Cell Therapy 1:44 p.m. June 12, 2014 - Seeking Alpha
Neuralstem NSI-189 Abstract Teases At Potential Greatness 9:14 a.m. May 28, 2014 - Seeking Alpha
Interesting CUR Put And Call Options For July 19th 12:10 p.m. May 19, 2014 - TheStreet.com
A trader's look at Neuralstem 3:07 p.m. May 14, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 6:29 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
BrainStorm to start Phase 2 ALS trial 10:12 a.m. April 28, 2014 - Seeking Alpha
Interesting CUR Put And Call Options For June 21st 11:54 a.m. April 22, 2014 - TheStreet.com
Neuralstem's Cell Therapy Is Working, And This Is Just The Beginning 8:41 a.m. April 22, 2014 - Seeking Alpha
Stem cell trial for spinal cord injury to proceed 10:02 a.m. April 16, 2014 - Seeking Alpha
Aastrom: Mice Scared Me Away 10:51 a.m. March 26, 2014 - Seeking Alpha
Senators introduce regenerative medicine bill 1:40 p.m. March 14, 2014 - Seeking Alpha
Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS 10:30 a.m. March 11, 2014 - Seeking Alpha
Osiris Therapeutics: Poised For Another Breakout 2:07 a.m. March 11, 2014 - Seeking Alpha
Major stem cell discovery might not be so major 2:32 p.m. March 10, 2014 - Seeking Alpha
10-K: NEURALSTEM, INC. 6:30 a.m. March 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial 9:15 a.m. Aug. 4, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks -- Research on Dynavax Technologies, Synergy Pharma, Infinity Pharma, and Neuralstem 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder 9:15 a.m. June 25, 2014 - PR Newswire - PRF
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress 9:15 a.m. June 19, 2014 - PR Newswire - PRF
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting 9:15 a.m. June 18, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "The FDA is Not the Enemy" 9:26 a.m. June 9, 2014 - ACCESSWIRE
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 6:50 a.m. May 29, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "Most men would rather deny a hard truth than face it" 11:36 a.m. May 28, 2014 - ACCESSWIRE
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting 9:28 a.m. May 23, 2014 - PR Newswire - PRF
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update 9:15 a.m. May 12, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings 1:34 p.m. May 9, 2014 - PR Newswire - PRF
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors 9:15 a.m. May 8, 2014 - PR Newswire - PRF
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego 9:15 a.m. April 16, 2014 - PR Newswire - PRF
Equities Updates on Top Gainers -- Research on E-Commerce China Dangdang, Neuralstem, Cytokinetics, and Nu Skin Enterprises 1:30 p.m. April 10, 2014 - PR Newswire - PRF
Neuralstem Principal Investigator, Dr. Eva Feldman, To Present Published ALS Trial Phase I Data At Medical Conference 9:15 a.m. April 7, 2014 - PR Newswire - PRF
Study Shows Neuralstem Cells Transplanted Into Brain Significantly Improve Post-Stroke Symptoms in Rats 9:15 a.m. March 28, 2014 - PR Newswire - PRF
Equities Recording New Highs: Generac Holding, Sempra Energy, Neuralstem, and Great Plains Energy 9:41 a.m. March 18, 2014 - PR Newswire - PRF
Final Results Of Neuralstem Phase I Stem Cell Trial In Amyotrophic Lateral Sclerosis Published In Annals of Neurology 9:15 a.m. March 17, 2014 - PR Newswire - PRF
Breakthroughs on the Horizon for CTE and Other Neurodegenerative Diseases 1:22 p.m. March 13, 2014 - ACCESSWIRE
(0)
(0)